Inventor · disambiguated record
Peter Shaw
Also filed as: SHAW PETER · SHAW PETER M
11 granted patents·11 pending applications·130 citations·filing 1980–2022
89Inventor score
Top patents by PatentIndex Score
22 records- 0185US7932031B2Methods for determining sensitivity to microtubule-stabilizing agents comprising ixabepilone by measuring the level of estrogen receptor 1BRISTOL MYERS SQUIBB CO·Filed 2007·Granted Apr 26, 2011·12 cites·2 claims
- 0285US7537891B2Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cellsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted May 26, 2009·8 cites·1 claims
- 0379US9932637B2Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereofCELERA CORP·Filed 2016·Granted Apr 3, 2018·2 cites·25 claims
- 0474US11708610B2Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereofCELERA CORP·Filed 2021·Granted Jul 25, 2023·0 cites·14 claims
- 0570US7504211B2Methods of using EPHA2 for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cellsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Mar 17, 2009·3 cites·1 claims
- 0665US10982281B2Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereofCELERA CORP·Filed 2018·Granted Apr 20, 2021·0 cites·18 claims
- 0763US5891696ACompositions for cytochrome P450 biotransformation reactionsPANVERA CORP·Filed 1997·Granted Apr 6, 1999·18 cites·22 claims
- 0862US4468811ATamper-evident closure for bagSMITH BROS WHITEHAVEN LTD·Filed 1983·Granted Aug 28, 1984·65 cites·15 claims
- 0960US2006046249A1Identification of polynucleotides and polypetide for predicting activity of compounds that interact with protein tyrosine kinase and or protein tyrosine kinase pathwaysHUANG FEI·Filed 2003·Application pending·0 cites
- 1060US2007166704A1Identification of polynucleotides and polypeptide for predicting activity of compounds that interact with protein tyrosine kinases and/or protein tyrosine kinase pathwaysHUANG FEI·Filed 2003·Application pending·0 cites
- 1160US2014221484A1Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 1257US2005272054A1Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereofAPPLERA CORP·Filed 2004·Application pending·0 cites
- 1357US2022119866A1Snp markers of drug reduced susceptibility related evolutionary branches of clostridium difficile, method for identifying strain category, and use thereofBGI SHENZHEN·Filed 2021·Application pending·0 cites
- 1452US2010190172A1Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereofCELERA CORP·Filed 2010·Application pending·0 cites
- 1550US2024327929A1Dosage regimen for administration of belzutifanBATEMAN THOMAS J·Filed 2022·Application pending·0 cites
- 1647US2004259942A1Modulation of stat activityFiled 2002·Application pending·0 cites
- 1746US2006121511A1Biomarkers and methods for determining sensitivity to microtubule-stabilizing agentsLEE HYERIM·Filed 2005·Application pending·0 cites
- 1844US2022259656A1Blood biomarker and genetic markers associated with response to crth2 receptor antagonistsMEHROTRA DEVAN V·Filed 2020·Application pending·0 cites
- 1940US6319678B1Process for glucuronidation screeningPANVERA CORP·Filed 1999·Granted Nov 20, 2001·10 cites·1 claims
- 2039US12071666B2Human genetic markers associated with response to treatments that target clostridium difficile toxin BMERCK SHARP & DOHME LLC·Filed 2017·Granted Aug 27, 2024·0 cites·30 claims
- 2136US2006019284A1Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in lung cancer cellsHUANG FEI·Filed 2005·Application pending·0 cites
- 2227US4331491AMethod of making packaging using a tinted adhesive laminateSMITH BROS WHITEHAVEN LTD·Filed 1980·Granted May 25, 1982·12 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Peter Shaw files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →